Delivery Order SPE2DB22D2103-SPE2DB25FR9RM
- Not listed
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with a completion date of August 29, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, utilizes firm fixed price pricing with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30. The contract, designated as non-competitive with a firm fixed price structure, is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the prime contractor and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. ORGOVYX...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $1,385.52. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 28, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a single pharmaceutical procurement from the vendor's corporate office located in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This $8,313.12 firm fixed price delivery order, with a completion date of September 8, 2025, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit dose) valued at $1,385.52 with a firm fixed price arrangement. This non-competitive, non-set-aside delivery order was awarded on August 8, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price arrangement. The award, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9RMDelivery Order
This delivery order, valued at $5,542.08, awards AmerisourceBergen Drug Corp the supply of ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract with the Defense Logistics Agency. The award, issued on August 14, 2025, with completion targeted for September 5, 2025, represents a non-competitive delivery order issued without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. ORGOVYX is a prescription medication used in the treatment of advanced prostate cancer, indicating this order supports medical supply requirements for military healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's position as a major pharmaceutical distributor and its demonstrated capability to fulfill federal procurement requirements through open competition underpin its role in supporting the DLA's medical supply chain for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/14/25 |